Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

Persistent HIV-1 Seronegative Status is Associated with Lower CD8+ T Cell Activation.

Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF.

J Infect Dis. 2015 Aug 26. pii: jiv425. [Epub ahead of print]

PMID:
26310308
2.

Incident Vertebral Fractures in Children with Leukemia During the Four Years Following Diagnosis.

Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Ann Matzinger M, Lentle B, Stephure D, Stein R, Marie Sbrocchi A, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2015 Jul 14:JC20152176. [Epub ahead of print]

PMID:
26171800
3.

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.

Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, Leadabrand KS, Milush JM, York VA, Raposo RA, Cheng RG, Eriksson EM, McMahan V, Glidden DV, Shiboski S, Grant RM, Nixon DF, Kallás EG.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8379-84. doi: 10.1073/pnas.1501443112. Epub 2015 Jun 22.

4.

Ending Sexual HIV Transmission: Lessons Learned from Perinatal HIV.

Weber S, Grant RM.

J Assoc Nurses AIDS Care. 2015 Sep-Oct;26(5):520-5. doi: 10.1016/j.jana.2015.05.005. Epub 2015 Jun 19. No abstract available.

PMID:
26096627
5.

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).

Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, Vargas L, Amico KR, Chodacki P, Fernandez T, Avelino-Silva VI, Burns D, Grant RM; iPrEx Study Team.

AIDS Behav. 2015 Jun 16. [Epub ahead of print]

PMID:
26078115
6.

Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study.

Koester KA, Liu A, Eden C, Amico KR, McMahan V, Goicochea P, Hosek S, Mayer KH, Grant RM.

AIDS Care. 2015 May 22:1-6. [Epub ahead of print]

PMID:
26001026
7.

Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco.

Truong HH, Pipkin S, OʼKeefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):606-9. doi: 10.1097/QAI.0000000000000681.

PMID:
25967271
8.

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.

Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LM, Wang F, Lama JR, Chariyalertsak S, Guanira JV, Buchbinder S, Bekker LG, Schechter M, Veloso VG, Grant RM; Preexposure Prophylaxis Initiative Study Team.

Clin Infect Dis. 2015 Aug 15;61(4):572-80. doi: 10.1093/cid/civ324. Epub 2015 Apr 23.

PMID:
25908682
9.

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.

Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereuz P, Guanira JV, Grinsztejn B, Chariyalertsak S, Bekker LG, Grant RM; iPrEx Study Team.

J Infect Dis. 2015 Apr 20. pii: jiv239. [Epub ahead of print]

PMID:
25895984
10.

Weighing the risk of drug resistance with the benefits of HIV preexposure prophylaxis.

Grant RM, Liegler T.

J Infect Dis. 2015 Apr 15;211(8):1202-4. doi: 10.1093/infdis/jiu678. Epub 2015 Jan 13. No abstract available.

11.

Transactional sex and prevalence of STIs: a cross-sectional study of MSM and transwomen screened for an HIV prevention trial.

Solomon MM, Nureña CR, Tanur JM, Montoya O, Grant RM, Jeff McConnell J.

Int J STD AIDS. 2014 Dec 17. pii: 0956462414562049. [Epub ahead of print]

PMID:
25520017
12.

Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women.

Grant RM, Liegler T, Defechereux P, Kashuba AD, Taylor D, Abdel-Mohsen M, Deese J, Fransen K, De Baetselier I, Crucitti T, Bentley G, Agingu W, Ahmed K, Damme LV.

AIDS. 2015 Jan 28;29(3):331-7.

PMID:
25503265
13.

The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures.

Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr R, Cabral DA, Couch R, Cummings EA, Fernandez CV, Grant RM, Rodd C, Sbrocchi AM, Scharke M, Rauch F, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2015 Mar;100(3):1018-27. doi: 10.1210/jc.2014-3096. Epub 2014 Dec 11.

PMID:
25494661
14.

Streamlining HIV testing for HIV preexposure prophylaxis.

Guanira JV, Leigler T, Kallas E, Schechter M, Sharma U, Glidden D, Grant RM; iPrEx Study Team.

J Clin Microbiol. 2015 Jan;53(1):179-83. doi: 10.1128/JCM.01540-14. Epub 2014 Nov 5.

15.

Gay and bisexual men engage in fewer risky sexual behaviors while traveling internationally: a cross-sectional study in San Francisco.

Truong HM, Fatch R, Grasso M, Robertson T, Tao L, Chen YH, Curotto A, McFarland W, Grant RM, Reznick O, Raymond HF, Steward WT.

Sex Transm Infect. 2015 May;91(3):220-5. doi: 10.1136/sextrans-2014-051660. Epub 2014 Oct 29.

PMID:
25355773
16.

Reply to Boyd et al.

Solomon MM, Mayer KH, Glidden DV, Guanira JV, Grant RM.

Clin Infect Dis. 2015 Jan 15;60(2):327. doi: 10.1093/cid/ciu814. Epub 2014 Oct 16. No abstract available.

17.

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV; iPrEx study team.

Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.

PMID:
25065857
18.

Regulatory considerations for antiretroviral prophylaxis to prevent HIV acquisition.

Miller V, Grant RM.

Clin Pharmacol Ther. 2014 Aug;96(2):153-5. doi: 10.1038/clpt.2014.114. Review.

PMID:
25056397
19.

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA; International Antiviral Society-USA Panel.

JAMA. 2014 Jul 23-30;312(4):390-409. doi: 10.1001/jama.2014.7999. Erratum in: JAMA. 2014 Jul 23-30;312(4):403. JAMA. 2014 Aug 13;312(6):652.

PMID:
25038358
20.

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.

Solomon MM, Mayer KH, Glidden DV, Liu AY, McMahan VM, Guanira JV, Chariyalertsak S, Fernandez T, Grant RM; iPrEx Study Team.

Clin Infect Dis. 2014 Oct;59(7):1020-6. doi: 10.1093/cid/ciu450. Epub 2014 Jun 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk